Pemphigoid gestationis

Clinics in Dermatology

Volumn 30, Issue 1, 2012, Pages 51-55

  Lipozenčić, Jasna ^a   Ljubojevic, Suzana ^a   Bukvić Mokos, Zrinka ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AUTOANTIBODY; AZATHIOPRINE; BP180 ANTIBODY; COMPLEMENT COMPONENT C3; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHOTREXATE; MINOCYCLINE; NICOTINAMIDE; PREDNISONE; PYRIDOXINE; STEROID; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; BULLOUS SKIN DISEASE; CLINICAL FEATURE; COMPLEMENT DEPOSITION; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; HISTOPATHOLOGY; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; INTRAUTERINE GROWTH RETARDATION; LABORATORY TEST; LAMINA LUCIDA; MATERNAL MORBIDITY; MATERNAL MORTALITY; PATHOGENESIS; PEMPHIGOID GESTATIONIS; PLASMAPHERESIS; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; PUERPERIUM; RECURRENT DISEASE; SUBEPIDERMAL VESICLE; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; AUTOANTIGENS; BASEMENT MEMBRANE; DERMATOLOGIC AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; NON-FIBRILLAR COLLAGENS; PEMPHIGOID GESTATIONIS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PROGNOSIS;

EID: 83155160955     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.03.009     Document Type: Article

References (23)

1. Al-Fouzan A.S., Galadari I., Oumeish O.Y. Herpes gestationis (pemphigoid gestationis). Clin Dermatol 2006, 24:109-112.
2. Shornick J.K., Bangert J.L., Freeman R.G., Gilliam J.N. Herpes gestationis: clinical and histologic features of twenty-eight cases. J Am Acad Dermatol 1983, 8:214-224.
3. Wojnarovska F, Venning VA Immunobullous diseases. Rook's textbook of dermatology 2010, 40:40.1-40.62. Wiley-Blackwell Publishing, Oxford, UK. 8th ed. T. Burns, S. Breatnach, N. Cox, C. Griffiths (Eds.).
4. Freiman A., Pabby A. Pemphigoid gestationis. MedScape Accessed: Aug 26, 2010. http://emedicine.medscape.com/article/1063499-overview.
5. Tunzi M., Gray G.R. Common skin conditions during pregnancy. Am Fam Physician 2007, 75:211-218.
6. Cobo M.F., Santi C.G., Maruta C.W., et al. Pemphigoid gestationis: clinical and laboratory evaluation. Clinics 2009, 64:1043-1047.
7. Triki S., Zeglaoui F., Fazaa B., et al. Pemphgoid gestationis. A report of 30 cases. Tunis Med 2006, 84:275-278.
8. Rodrigues Cdos S., Filipe P., Solana Mdel M., et al. Persistent herpes gestationis treated with high-dose intravenous immunoglobulin. Acta Derm Venereol 2007, 87:184-186.
9. Shornick J.K. Pemphigoid gestationis (herpes gestationis). Fitzpatrick's dermatology in general medicine 2008, 490-493. McGraw Hill Medical, New York. 7th ed. K. Wolff, L.A. Goldsmith, S.I. Katz, B.A. Gilchrest, A.S. Paller, D.J. Jeffell (Eds.).
10. Di Zenzo G., Calabresi V., Grosso F., et al. Intracellular and extracellular domains of BP 180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies. J Invest Dermatol 2007, 127:864-873.
11. Bedocs P.M., Kumar V., Mahon M.J. Pemphigoid gestationis: a rare case and review. Arch Gynecol Obstet 2009, 279:235-238.
12. Semkova K., Black M. Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol 2009, 145:138-144.
13. Chi C.C., Wang S.H., Charles-Holmes R., et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol 2009, 160:1222-1228.
14. Barnadas M.A., Rubiales M.V., González M.J., et al. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis. Int J Dermatol 2008, 47:1245-1249.
15. Boulinguez S., Bédane C., Prost C., et al. Chronic pemphigoid gestationis: comparative clinical and immunopathological study of 10 patients. Dermatology 2003, 206:113-119.
16. Braun-Falco O., Plewig G., Wolff H.H., et al. Blistering diseases. Dermatology 2000, 650-695. Springer Verlag, Berlin. 2nd ed. O. Braun Falco, G. Plewig, H.H. Wolff, R.K. Winkelmann (Eds.).
17. Sitaru C., Dähnrich C., Probst C., et al. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 2007, 16:770-777.
18. Roger D., Vaillant L., Fignon A., et al. Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women. Arch Dermatol 1994, 130:734-739.
19. Panko J., Florell S.R., Hadley J., et al. Neonatal pemphigus in an infant born to a mother with serologic evidence of both pemphigus vulgaris and gestational pemphigoid. J Am Acad Dermatol 2009, 60:1057-1062.
20. Olasz E.B., Yancey K.B. Bullous pemphigoid and related subepidermal autoimmune blistering diseases. Curr Dir Autoimmune 2008, 10:141-166.
21. Ambros-Rudolph C.M., Müllegger R.R., Vaughan-Jones S.A., et al. The specific dermatoses of pregnancy revisited and reclassified: Results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 2006, 54:395-404.
22. Wöhrl S., Geausau A., Karlhofer F., et al. Pemphigoid gestationis: treatment with immunoapheresis. J Dtsch Dermatol Ges 2003, 1:126-130.
23. Jenkins R.E., Hern S., Black M.M. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol 1999, 24:255-259.